Company news
Axsome Therapeutics, Inc. news in 2019
Axsome Therapeutics, Inc.'s news releases, calls and decks from 2019, newest first.
Axsome Therapeutics Announces AXS-07 Achieves Co-Primary and Key Secondary Endpoints in MOMENTUM Phase 3 Migraine Trial in Patients with History of Inadequate Response
December 29, 2019
Axsome Therapeutics Announces Closing of $200 Million Public Offering of Common Stock, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
December 22, 2019
Axsome Therapeutics Announces Pricing of Public Offering of $174 Million of Shares of Common Stock
December 18, 2019
Axsome Therapeutics Announces AXS-05 Achieves Primary Endpoint in GEMINI Phase 3 Trial in Major Depressive Disorder
December 15, 2019
Axsome Therapeutics Announces AXS-12 Achieves Primary Endpoint in CONCERT Phase 2 Trial in Narcolepsy
December 2, 2019
Axsome Therapeutics Reports Third Quarter 2019 Financial Results and Provides Business Update
November 6, 2019
Axsome Therapeutics Announces Results of MINDSET Physician Survey Affirming Unmet Need and Favorable Profile of AXS-07 in the Acute Treatment of Migraine
October 27, 2019
Axsome Therapeutics Completes Patient Enrollment in the CONCERT Phase 2 Trial of AXS-12 in Narcolepsy
October 20, 2019
Axsome Therapeutics Announces Completion of Patient Enrollment in the GEMINI Phase 3 Trial of AXS-05 in Major Depressive Disorder
October 15, 2019
Axsome Therapeutics Announces AXS-05 Achieves Primary Endpoint in Phase 2 Trial in Smoking Cessation
April 14, 2019
Decks in 2019
- Technical Presentation (December 2019)
Technical · 26 slides · Dec 30, 2019
- GEMINI Phase 3 Trial of AXS-05 in MDD Topline Results Conference Call (December 2019)
Conference · 22 slides · Dec 16, 2019
- Technical Presentation (December 2019)
Technical · 26 slides · Dec 3, 2019
- Investor Presentation (November 2019)
Investor deck · 30 slides · Nov 7, 2019
- ASCP 2019 Oral Session
Conference · 17 slides · May 2019
- Investor Presentation (March 2019)
Investor deck · 41 slides · Mar 14, 2019
- Technical Presentation (January 2019)
Technical · 22 slides · Jan 7, 2019
- Investor Presentation (January 2019)
Investor deck · 41 slides · Jan 7, 2019